Thyroid cancer treatment

A tétel rövid nézete
dc.contributor.advisorPorszász , Róbert
dc.contributor.advisordeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.contributor.authorSaito, Zen
dc.contributor.departmentDE--Általános Orvostudományi Kar
dc.contributor.opponentHalasi, Barbara Dóra
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Igazságügyi Orvostani Intézet
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.date.accessioned2025-05-26T12:50:41Z
dc.date.available2025-05-26T12:50:41Z
dc.date.created2025-03-14
dc.description.abstractABSTRACT Thyroid cancer is one of the most common endocrine tumors in the community, and it has been on the rise for several decades. The disease is categorized into four subtypes of cancer: papillary, follicular, medullary, and anaplastic thyroid cancer, each of which is treated differently. Although surgery and radioactive iodine therapy remain the primary treatments for differentiated thyroid cancer, patients with advanced or refractory illness require innovative pharmaceutical medications. The pharmacological treatment of thyroid cancer has increasingly expanded to include targeted, chemotherapy, and hormone replacement. Tyrosine kinase inhibitors (TKIs), such as sorafenib, lenvatinib, and cabozantinib, have demonstrated encouraging benefits in metastatic or progressing thyroid cancer. Furthermore, molecular targeted medicines such as BRAF, RET, and MEK inhibitors have altered the therapeutic landscape by presenting prospective personalized treatment alternatives. Immunotherapy is a new field that could help overcome drug resistance and enhance patient outcomes. However, there are still other issues, including as the emergence of drug resistance, hazardous effects, and the need for long-term efficacy trials. Current research efforts are focused on optimizing combination therapy, identifying new molecular pathways, and applying artificial intelligence to medication design and treatment decision making. Many clinical trials are still underway to test the safety and efficacy of new medications, which could lead to improved treatment in the near future.
dc.description.courseáltalános orvos
dc.description.courselangangol
dc.description.degreeegységes, osztatlan
dc.format.extent38
dc.identifier.urihttps://hdl.handle.net/2437/390434
dc.language.isoen
dc.rights.infoHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectThyroid cancer
dc.subjectpapillary thyroid cancer
dc.subject.dspaceMedicine
dc.titleThyroid cancer treatment
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
thyroid cancer treatment PDF LAST.pdf
Méret:
1.3 MB
Formátum:
Adobe Portable Document Format
Leírás:
Megjelenítés
Engedélyek köteg
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
license.txt
Méret:
1.94 KB
Formátum:
Item-specific license agreed upon to submission
Leírás:
Letöltés
Gyűjtemények
Theses (Faculty of Medicine)